---
title: "DaVita | 8-K: FY2025 Q4 Revenue Beats Estimate at USD 3.62 B"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/274558142.md"
datetime: "2026-02-02T21:09:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274558142.md)
  - [en](https://longbridge.com/en/news/274558142.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274558142.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/274558142.md) | [繁體中文](https://longbridge.com/zh-HK/news/274558142.md)


# DaVita | 8-K: FY2025 Q4 Revenue Beats Estimate at USD 3.62 B

Revenue: As of FY2025 Q4, the actual value is USD 3.62 B, beating the estimate of USD 3.506 B.

EPS: As of FY2025 Q4, the actual value is USD 2.94, missing the estimate of USD 3.54.

EBIT: As of FY2025 Q4, the actual value is USD 709.32 M.

The provided reference indicates that a press release announcing financial results for the quarter ended December 31, 2025, was issued by DaVita Inc. on February 2, 2026, and furnished as Exhibit 99.1 to a Form 8-K filing. However, the actual financial results, operational metrics, or any forward-looking outlook or guidance from this press release are not included within the provided text.

### 相关股票

- [DaVita (DVA.US)](https://longbridge.com/zh-CN/quote/DVA.US.md)

## 相关资讯与研究

- [Evaluating DaVita (DVA) After Prolonged Share Price Weakness And Undervalued Fair Value Estimate](https://longbridge.com/zh-CN/news/272864688.md)
- [A Digital Guardian: AI-Powered Insights Bring Patients and Clinicians Closer](https://longbridge.com/zh-CN/news/281527100.md)
- [Wealth First Promoters Confirm 74% Stake With No Encumbrance in FY26](https://longbridge.com/zh-CN/news/281530653.md)
- [Inky Updates Bylaws Following Recent Fiscal Year Change](https://longbridge.com/zh-CN/news/281297268.md)
- [Research Alert: CFRA Keeps Hold Opinion On Shares Of Carnival Corp.](https://longbridge.com/zh-CN/news/281028740.md)